Skip to main content
Log in

Increased myeloperoxidase activity is a risk factor for ischemic heart disease in patients with diabetes mellitus

  • Published:
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry Aims and scope Submit manuscript

Abstract

Using a previously developed spectrophotometric method (Bioorg. Khim. 2009, vol. 35, pp. 629–639) a significant increase of myeloperoxidase (MPO) activity (versus healthy control) was found in blood plasma of patients with type 2 diabetes mellitus (DM2) without cardiovascular complications, and also in patients with ischemic heart disease (IHD). The plasma MPO concentration measured by an enzyme-linked immunosorbent assay was significantly higher only in blood plasma of patients with DM2 and IHD. A significant positive correlation between blood MPO activity and blood MPO content was observed only in blood plasma samples from healthy donors. Increased MPO activity did not correlate with MPO concentration in blood plasma of patients with DM2 and DM2 with IHD. Taken together, these results indicate that studies on the MPO role in the development of pathological processes should include simultaneous determination of both the amount of enzyme and its peroxidase activity in blood of patients. The proposed approach gives comprehensive information about the relationship between MPO activity and MPO concentration in patient’s blood. Since the high concentration of MPO is a diagnostically important parameter for the prediction of development of endothelial dysfunction and cardiovascular diseases, the obtained results point to the contribution of MPO-dependent reactions in cardiovascular complications associated with diabetes mellitus. MPO activity may serve as an additional diagnostic criterion for determination of risk of IHD in DM patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

DM2:

type 2 diabetes mellitus

ELISA:

enzyme-linked immunosorbent assay

fMLP:

N-formyl-Met-Leu-Phe

IHD:

ischemic heart disease

LDL:

low density lipoproteins

MPO:

myeloperoxidase

References

  1. Zhang, C., Yang, J., and Jennings, L.K., Diabetes, 2004, vol. 53, pp. 2950–2959.

    Article  CAS  Google Scholar 

  2. Jacobi, J., Sela, S., Cohen, H.I., Chezar, J., and Kristal, B., Am. J. Physiol. Heart Circ. Physiol., 2006, vol. 290, pp. H2051–H2058.

    Article  CAS  Google Scholar 

  3. Shurtz-Swirski, R., Sela, S., Herskovits, A.T., Shasha, S.M., Shapiro, G., Nasser, L., and Kristal, B., Diabetes Care, 2001, vol. 24, pp. 104–110.

    Article  CAS  Google Scholar 

  4. Stegenga, M.E., van der Crabben, S.N., Blümer, R.M.E., Levi, M., Meijers, J.C.M., Serlie, M.J., Tanck, M.W.T., Sauerwein, H.P., and van der Poll, T., Blood, 2008, vol. 112, pp. 82–89.

    Article  CAS  Google Scholar 

  5. Podrez, E.A., Abu-Soud, H.M., Hazen, S.L., Free Radic. Biol. Med., 2000, vol. 28, pp. 1717–1725.

    Article  CAS  Google Scholar 

  6. Lau, D. and Baldus, S., Pharmacol. Ther., 2006, vol. 111, pp. 16–26.

    Article  CAS  Google Scholar 

  7. Nicholls, S.J. and Hazen, S.L., J. Lipid Res., 2009, vol. 50, pp. 346–351.

    Article  Google Scholar 

  8. Daugherty, A., Dunn, J.L., Rateri, D.L., and Heinecke, J.W., J. Clin. Invest., 1994, vol. 94, pp. 437–444.

    Article  CAS  Google Scholar 

  9. Stenvinkel, P., Rodríguez-Ayala, E., Massy, Z.A., Qureshi, A.R., Barany, P., Fellström, B., Heimburger, O., Lindholm, B., and Alvestrand, A., Clin. J. Am. Soc. Nephrol., 2006, vol. 1, pp. 281–287.

    Article  CAS  Google Scholar 

  10. Boker, T., Augustin, A.J., Breipohl, W., Spitznas, M., and Lutz, J., Graefes Arch. Clin. Exp. Ophthalmol., 1994, vol. 232, pp. 652–656.

    Article  CAS  Google Scholar 

  11. Uchimura, K., Nagasaka, A., Hayashi, R., Makino, M., Nagata, M., Kakizawa, H., Kobayashi, T., Fujiwara, K., Kato, T., Iwase, K., Shinohara, R., Kato, K., and Itoh, M., J. Diabetes Complications, 1999, vol. 13, pp. 264–270.

    Article  CAS  Google Scholar 

  12. Heilman, K., Zilmer, M., Zilmer, K., Lintrop, M., Kampus, P., Kals, J., and Tillmann, V., Diabetes Res. Clin. Pract., 2009, vol. 84, pp. 168–173.

    Article  CAS  Google Scholar 

  13. Schindhelm, R.K., Alssema, M., Diamant, M., Teerlink, T., Dekker, J.M., Kok, A., Kostense, P.J., Nijpels, G., Heine, R.J., and Scheffer, P.G., Metabolism, 2008, vol. 57, pp. 262–267.

    Article  CAS  Google Scholar 

  14. Gorudko, I.V., Cherkalina, O.S., Sokolov, A.V., Pulina, M.O., Zakharova, E.T., Vasilyev, V.B., Cherenkevich, S.N., and Panasenko, O.M., Bioorg. Khim., 2009, vol. 35, no. 5, pp. 1–11.

    Google Scholar 

  15. Sokolov, A.V., Ageeva, K.V., Pulina, M.O., Cherkalina, O.S., Samygina, V.R., Vlasova, I.I., Panasenko, O.M., Zakharova, E.T., and Vasilyev, V.B., Free Rad. Res., 2008, vol. 42, pp. 989–998.

    Article  CAS  Google Scholar 

  16. Gorudko, I.V., Timoshenko, A.V., Timoshenko, A.P., Vacker, A.V., Timoshenko, P.A., and Cherenkevich, S.N., Central East Eur. J. Oto-Rhino-Laryngol. Head Neck Surg., 1997, vol. 2, pp. 22–27.

    Google Scholar 

  17. Timoshenko, A.V., Kayser, K., and Gabius, H.J., Meth. Mol. Med., 1998, vol. 9, pp. 441–445.

    CAS  Google Scholar 

  18. Elgawish, A., Glomb, M., Friedlander, M., and Monnier, V.M., J. Biol. Chem., 1996, vol. 272, pp. 12964–12971.

    Google Scholar 

  19. Moreno-Navarrete, J.M., Ortega, F.J., Bassols, J., Ricart, W., and Fernández-Real, J.M., J. Clin. Endocrinol. Metab., 2009, vol. 94, pp. 4036–4044.

    Article  CAS  Google Scholar 

  20. Gewirtz, A.T., Fokin, V.V., Petasis, N.A., Serhan, C.N., and Madara, J.L., Am. J. Physiol. Cell Physiol., 1999, vol. 276, pp. C988–C994.

    CAS  Google Scholar 

  21. Bajaj, M.S., Kew, R.R., Webster, R.O., and Hyers, T.M., Inflammation, 1992, vol. 16, pp. 241–250.

    Article  CAS  Google Scholar 

  22. Singh, U., Devaraj, S., and Jialal, I., Clin. Chem., 2009, vol. 55, pp. 361–364.

    Article  CAS  Google Scholar 

  23. Gorudko, I.V., Vakhrusheva, T.V., Mukhortova, A.V., Cherenkevich, S.N., Timoshenko, A.V., Sergienko, V.I., and Panasenko, O.M., Biol. Membr., 2010, vol. 27, pp. 314–324.

    CAS  Google Scholar 

  24. Vlasova, I.I., Arnhold, J., Osipov, A.N., and Panasenko, O.M., Biochemistry (Moscow), 2006, vol. 71, pp. 825–837.

    Google Scholar 

  25. Hawkins, C.L. and Davies, M.J., Chem. Res. Toxicol., 2005, vol. 18, pp. 1600–1610.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. V. Gorudko.

Additional information

Original Russian Text © I.V. Gorudko, V.A. Kostevich, A.V. Sokolov, I.V. Buko, E.E. Konstantinova, N.L. Tsapaeva, E.V. Mironova, E.T. Zakharova, V.B. Vasilyev, S.N. Cherenkevich, O.M. Panasenko, 2011, published in Biomeditsinskaya Khimiya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gorudko, I.V., Kostevich, V.A., Sokolov, A.V. et al. Increased myeloperoxidase activity is a risk factor for ischemic heart disease in patients with diabetes mellitus. Biochem. Moscow Suppl. Ser. B 5, 307–312 (2011). https://doi.org/10.1134/S199075081103005X

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S199075081103005X

Keywords

Navigation